HIV-1 integration: An interplay between HIV-1 integrase, cellular and viral proteins

AIDS Reviews

Volumn 7, Issue 1, 2005, Pages 26-43

  Van Maele, Bénédicte ^a   Debyser, Zeger ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

Author keywords

HIV 1 integration; Integrase

Indexed keywords

ANTIVIRUS AGENT; BINDING PROTEIN; CELL PROTEIN; COMPLEMENTARY DNA; DNA DEPENDENT PROTEIN KINASE; EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; HEAT SHOCK PROTEIN 60; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP PROTEIN; HOST FACTOR 1; INTEGRASE; INTEGRASE INTERACTOR 1 PROTEIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; NUCLEOCAPSID PROTEIN; RECOMBINANT ENZYME; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME; VIRUS PROTEIN;

DNA REPAIR; ENZYME MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN DETERMINATION; REVIEW; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

APOPTOSIS; HIV INTEGRASE; HIV-1; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 18744371922     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Engelman A, Mizuuchi K, Craigie R. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 1991; 67:1211-21.
2. Farnet CM, Haseltine WA. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc Natl Acad Sci USA 1990; 87:4164-8.
3. Miller M, Farnet C, Bushman F. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997;71:5382-90.
4. Lapadat-Tapolsky M, De Rocquigny H, Van Gent D, et al. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res 1993;21:831-9.
5. Yoder K, Bushman F. Repair of gaps in retroviral DNA integration intermediates. J Virol 2000;74:11191-200.
6. Engelman A, Englund G, Orenstein J, et al. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995;69:2729-36.
7. Masuda T, Planelles V, Krogstad P, et al. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol 1995;69:6687-96.
8. Tsurutani N, Kubo M, Maeda Y, et al. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J Virol 2000;74:4795-806.
9. Lee Y, Coffin J. Relationship of avian retrovirus DNA synthesis to integration in vitro. Mol Cell Biol 1991;11:1419-30.
10. Bushman FD, Craigie R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A 1991;88:1339-43.
11. Craigie R, Fujiwara T, Bushman F. The IN protein of Maloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 1990;62:829-37.
12. Kalpana GV, Marmon S, Wang W, et al. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 1994;266:2002-6.
13. Pierson T, Doms R. HIV-1 entry and its inhibition. Curr Top Microbiol Immunol 2003;281:1-27.
14. Wolff B, Sanglier J, Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the HIV type 1 Rev protein and Rev-dependent mRNA. Chem Biol 1997; 4:139-47.
15. Farjot G, Sergeant A, Mikaelian I. A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear export signal and CRM-1. J Biol Chem 1999;274:17309-17.
16. Pumfery A, Deng L, Maddukuri A, et al. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 2003;1:343-62.
17. VerPlank L, Bouamr F, LaGrassa TJ, et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 2001;98:7724-9. Epub 2001 Jun 26.
18. Garrus J, von Schwedler U, Pornillos O, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001;107:55-65.
19. Sheehy A, Gaddis N, Choi J, et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-50.
20. Madani N, Kabat D. Cellular and viral specificities of HIV type 1 vif protein. J Virol 2000;74:5982-7.
21. Harris R, Bishop K, Sheehy A, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003;113:803-9.
22. Goncalves J, Santa-Maria M. HIV-1 Vif and APOBEC3G: Multiple roads to one goal. Retrovirology 2004;1:28.
23. Bieniasz P. Restriction factors: a defense against retroviral infection. Trends Microbiol 2003;11:286-91.
24. Stremlau M, Owens C, Perron M, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004;427:848-53.
25. Lee M, Craigie R. Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc Natl Acad Sci USA 1994;91:9823-7.
26. Chen H, Engelman A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc Natl Acad Sci USA 1998; 95:15270-4.
27. Lee M, Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci USA 1998;95:1528-33.
28. Carteau S, Gorelick RJ, Bushman FD. Coupled integration of HIV type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J Virol 1999;73:6670-9.
29. Cai M, Huang Y, Zheng R, et al. Solution structure of the cellular factor BAF responsible for protecting retroviral DNA from autointegration. Nat Struct Biol 1998;5:903-9.
30. Zheng R, Ghirlando R, Lee M, et al. Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc Natl Acad Sci USA 2000;97:8997-9002.
31. Dechat T, Vlcek S, Foisner R. Lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics. J Struct Biol 2000;129:335-45.
32. Segura-Totten M, Wilson K. BAF: roles in chromatin, nuclear structure and retrovirus integration. Trends Cell Biol 2004;14:261-6.
33. Furukawa K. LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction. J Cell Sci 1999;112:2485-92.
34. Furukawa K, Sugiyama S, Osouda S, et al. Barrier-to-autointegration factor plays crucial roles in cell cycle progression and nuclear organization in Drosophila. J Cell Sci 2003;116:3811-23. Epub 2003 Aug 5.
35. Wang X, Xu S, Rivolta C, et al. Barrier to autointegration factor interacts with the cone-rod homeobox and represses its transactivation function. J Biol Chem 2002;277:43288-300. Epub 2002 Sep 4.
36. Lin CW, Engelman A. The barrier-to-autointegration factor is a component of functional HIV type 1 preintegration complexes. J Virol 2003;77:5030-6.
37. Mansharamani M, Graham D, Monie D, et al. Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of HIV type 1 virions. J Virol 2003;77:13084-92.
38. Reil H, Bukovsky A, Gelderblom H, et al. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. Embo J 1998;17:2699-708.
39. Harris D, Engelman A. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J Biol Chem 2000;275:39671-7.
40. Suzuki Y, Yang H, Craigie R. LAP2alpha and BAF collaborate to organize the Moloney murine leukemia virus preintegration complex. Embo J 2004;28:28.
41. Farnet C, Bushman FD. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 1997;88:483-92.
42. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001;277:63-81.
43. Hindmarsh P, Ridky T, Reeves R, et al. HMG protein family members stimulate HIV type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol 1999;73:2994-3003.
44. Li L, Yoder K, Hansen MS, et al. Retroviral cDNA integration: stimulation by HMG I family proteins. J Virol 2000;74:10965-74.
45. Nissen M, Reeves R. Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y. J Biol Chem 1995;270:4355-60.
46. Reeves R, Wolffe A. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA. Biochemistry 1996;35:5063-74.
47. Scottoline B, Chow S, Ellison V, et al. Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev 1997;11:371-82.
48. Beitzel B, Bushman F. Construction and analysis of cells lacking the HMGA gene family. Nucleic Acids Res 2003;31:5025-32.
49. Henderson A, Bunce M, Siddon N, et al. High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the HIV type 1 proviral promoter. J Virol 2000;74:10523-34.
50. Van Lint C, Emiliani S, Ott M, et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. Embo J 1996;15:1112-20.
51. Roebuck K, Gu D, Kagnoff M. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. Aids 1996;10:819-26.
52. Rabbi M, Al-Harthi L, Roebuck K. TNF alpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 1997;237:422-9.
53. Henderson A, Holloway A, Reeves R, et al. Recruitment of SWI/SNF to the hHIV type 1 promoter. Mol Cell Biol 2004;24:389-97.
54. Acel A, Udashkin B, Wainberg M, et al. Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of HIV type 1 integrase. J Virol 1998;72:2062-71.
55. Jeggo P. DNA breakage and repair. Adv Genet 1998;38:185-218.
56. Gottlieb T, Jackson S. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 1993; 72:131-42.
57. Blunt T, Finnie N, Taccioli G, et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995;80:813-23.
58. Danska J, Holland D, Mariathasan S, et al. Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes. Mol Cell Biol 1996;16:5507-17.
59. Daniel R, Katz R, Skalka A. A role for DNA-PK in retroviral DNA integration. Science 1999;284:644-7.
60. Daniel R, Greger J, Katz R, et al. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway. J Virol 2004;78:8573-81.
61. Baekelandt V, Claeys A, Cherepanov P, et al. DNA-Dependent protein kinase is not required for efficient lentivirus integration. J Virol 2000;74:11278-85.
62. Smith G, Jackson S. The DNA-dependent protein kinase. Genes Dev 1999;13:916-34.
63. Li L, Olvera J, Yoder K, et al. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. Embo J 2001;20:3272-81.
64. Jeanson L, Subra F, Vaganay S, et al. Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. Virology 2002;300:100-8.
65. Kilzer J, Strecker T, Beitzel B, et al. Roles of host cell factors in circularization of retroviral DNA. Virology 2003;314:460-7.
66. Lobel L, Murphy J, Goff S. The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol 1989;63:2629-37.
67. Brown P, Bowerman B, Varmus HE, et al. Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci USA 1989;86:2525-9.
68. Jeanson L, Mouscadet J. Ku represses the HIV-1 transcription: identification of a putative Ku binding site homologous to the mouse mammary tumor virus NRE1 sequence in the HIV-1 long terminal repeat. J Biol Chem 2002;277:4918-24.
69. Lee S, Kim C. DNA-dependent protein kinase complex: a multifunctional protein in DNA repair and damage checkpoint. Mol Cells 2002;13:159-66.
70. D'Amours D, Desnoyers S, D'Silva I, et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999;342:249-68.
71. Ha H, Juluri K, Zhou Y, et al. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc Natl Acad Sci USA 2001;98:3364-8.
72. Ota K, Kameoka M, Tanaka Y, et al. Expression of histone acetyltransferase was downregulated in poly(ADP-ribose) polymerase-1-deficient murine cells. Biochem Biophys Res Commun 2003;310:312-7.
73. Kameoka M, Nukuzuma S, Itaya A, et al. RNA interference directed against Poly(ADP-Ribose) polymerase 1 efficiently suppresses HIV type 1 replication in human cells. J Virol 2004;78:8931-4.
74. Goodarzi A, Block W, Lees-Miller S. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog Cell Cycle Res 2003;5:393-411.
75. Zhou B, Elledge S. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-9.
76. Daniel R, Kao G, Taganov K, et al. Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc Natl Acad Sci USA 2003;100:4778-83. Epub 2003 Apr 4.
77. Roshal M, Kim B, Zhu Y, et al. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem 2003; 278:25879-86.
78. Thompson L, Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 2001; 477:131-53.
79. Madura K, Dohmen R, Varshavsky A. N-recognin/Ubc2 interactions in the N-end rule pathway. J Biol Chem 1993;268:12046-54.
80. Bailly V, Lamb J, Sung P, et al. Specific complex formation between yeast RAD6 and RAD18 proteins: a potential mechanism for targeting RAD6 ubiquitin-conjugating activity to DNA damage sites. Genes Dev 1994;8:811-20.
81. Bailly V, Lauder S, Prakash S, et al. Yeast DNA repair proteins Rad6 and Rad18 form a heterodimer that has ubiquitin conjugating, DNA binding, and ATP hydrolytic activities. J Biol Chem 1997;272:23360-5.
82. Mulder L, Chakrabarti L, Muesing M. Interaction of HIV-1 integrase with DNA repair protein hRad18. J Biol Chem 2002;277:27489-93.
83. Lau A, Kanaar R, Jackson S, et al. Suppression of retroviral infection by the RAD52 DNA repair protein. Embo J 2004;23:3421-9.
84. Carlson M, Laurent B. The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol 1994;6:396-402.
85. Muchardt C, Yaniv M. The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 1999;10:189-95.
86. Wang W, Cote J, Xue Y, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 1996; 15:5370-82.
87. Morozov A, Yung E, Kalpana GV. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci USA 1998;95:1120-5.
88. Cheng S, Davies K, Yung E, et al. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 1999;22:102-5.
89. Lee D, Sohn H, Kalpana G, et al. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 1999;399:487-91.
90. Lee D, Kim J, Seo T, et al. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 2002;277:22330-7.
91. Wu D, Kalpana G, Goff S, et al. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J Virol 1996;70:6020-8.
92. Craig E, Zhang Z, Davies K, et al. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. Embo J 2002;21:31-42.
93. Yung E, Sorin M, Pal A, et al. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat Med 2001;7:920-6.
94. Yung E, Sorin M, Wang E, et al. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J Virol 2004;78:2222-31.
95. Turelli P, Doucas V, Craig E, et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 2001;7:1245-54.
96. Daniel M, Koken M, Romagne O, et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 1993;82:1858-67.
97. Dyck J, Maul G, Miller W, et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994;76:333-43.
98. Berthoux L, Towers G, Gurer C, et al. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol 2003;77:3167-80.
99. Fink AL. Chaperone-mediated protein folding. Physiol Rev 1999; 79:425-49.
100. Parissi V, Calmels C, De Soultrait VR, et al. Functional interactions of HIV type 1 integrase with human and yeast HSP60. J Virol 2001;75:11344-53.
101. Bartz S, Pauza C, Ivanyi J, et al. An Hsp60 related protein is associated with purified HIV and SIV. J Med Primatol 1994;23:151-4.
102. Park S, Jung G. Human hepatitis B virus polymerase interacts with the molecular chaperone in Hsp60. J Virol 2001;75:6962-8.
103. Pirrotta V. Polycombing the genome: PcG, trxG, and chromatin silencing. Cell 1998;93:333-6.
104. Peytavi R, Hong S, Gay B, et al. HEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1. J Biol Chem 1999;274:1635-45.
105. Violot S, Hong S, Rakotobe D, et al. The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol 2003;77:12507-22.
106. Witte V, Laffert B, Rosorius O, et al. HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol Cell 2004;13:179-90.
107. Cherepanov P, Maertens G, Proost P, et al. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 2003;278:372-81.
108. Ge H, Si Y, Roeder R. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. Embo J 1998;17:6723-9.
109. Singh D, Ohguro N, Kikuchi T, et al. Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem Biophys Res Commun 2000; 267:373-81.
110. Dietz F, Franken S, Yoshida K, et al. The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem J 2002;366:491-500.
111. Singh D, Ohguro N, Chylack L, et al. Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses. Invest Ophthalmol Vis Sci 1999;40:1444-51.
112. Sharma P, Singh D, Fatma N, et al. Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 2000;276:1320-4.
113. Ganapathy V, Casiano CA. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum 2004;50:684-8.
114. Ochs R, Muro Y, Si Y, et al. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000;105:1211-20.
115. Stec I, Nagl S, van Ommen G, et al. The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett 2000;473:1-5.
116. Qiu C, Sawada K, Zhang X, et al. The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds. Nat Struct Biol 2002;9:217-24.
117. Maertens G, Cherepanov P, Debyser Z, et al. Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase (IN) interactor LEDGF/p75. J Biol Chem 2004;25:25.
118. Cherepanov P, Devroe E, Silver PA, et al. Identification of an evolutionarily-conserved domain in LEDGF/p75 that binds HIV-1 integrase. J Biol Chem 2004;14:14.
119. Shinohara T, Singh D, Fatma N. LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 2002;21:341-58.
120. Nishizawa Y, Usukura J, Singh D, et al. Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus. Cell Tissue Res 2001;305:107-14.
121. Maertens G, Cherepanov P, Pluymers W, et al. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003;278:33528-39.
122. Singh D, Fatma N, Kimura A, et al. LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes. Biochem Biophys Res Commun 2001;283:943-55.
123. Ganapathy V, Daniels T, Casiano C, et al. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun Rev 2003;2:290-7.
124. Daniels T, Zhang J, Gutierrez I, et al. Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 2004;26:26.
125. Wu X, Daniels T, Molinaro C, et al. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders. Cell Death Differ 2002;9:915-25.
126. Pluymers W, Cherepanov P, Schols D, et al. Nuclear localization of HIV type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology 1999;258:327-32.
127. Schroder AR, Shinn P, Chen H, et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002; 110:521-9.
128. Llano M, Vanegas M, Fregoso O, et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 2004;78:9524-37.
129. Busschots K, Vercammen J, Emiliani S, et al. The interaction of LEDGF/p75 with integrase is lentiviral-specific and promotes DNA binding. (submitted)
130. Emiliani S, Mousnier A, Busschots K, et al. Integrase mutants detective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication (submitted).
131. Emiliani S, Rain J, Maroun M, et al. Identification of LEDGF/p75 as an essential factor for HIV replication that binds integrase: a novel target for anti-HIV drug discovery. 10th Conference on Retroviruses and Opportunistic infections, Feb. 10th 2003, Boston 2003.
132. Llano M, Delgado S, Vanegas M, et al. LEDGF/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 2004;8:8.
133. Wu X, Li Y, Crise B, et al. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003;300:1749-51.
134. Summers M, Henderson L, Chance M, et al. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci 1992;1:563-74.
135. Freed E. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998;251:1-15.
136. Gorelick R, Gagliardi T, Bosche WJ, et al. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 1999;256:92-104.
137. De Rocquigny H, Gabus C, Vincent A, et al. Viral RNA annealing activities of HIV type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA 1992; 89:6472-6.
138. Rein A, Henderson L, Levin J. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem Sci 1998;23:297-301.
139. Lener D, Tanchou V, Roques B, et al. Involvement of HIV-1 nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem 1998;273:33781-6.
140. Hameau L, Jeusset J, Lafosse S, et al. HIV type 1 central DNA flap: dynamic terminal product of plus-strand displacement DNA synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein. J Virol 2001;75:3301-13.
141. Carteau S, Batson S, Poljak L, et al. HIV type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J Virol 1997;71:6225-9.
142. Poljak L, Batson S, Ficheux D, et al. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. J Mol Biol 2003;329:411-21.
143. Gao K, Gorelick R, Johnson D, et al. Cofactors for HIV type 1 cDNA integration in vitro. J Virol 2003;77:1598-603.
144. Buckman J, Bosche W, Gorelick R. HIV type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J Virol 2003;77:1469-80.
145. Coffin J, Hughes S, Varmus H. Retroviruses Cold Spring Harbor, NY: Cold Spring Harbor Press, 1997.
146. Wu X, Liu H, Xiao H, et al. HIV type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol 1999;73:2126-35.
147. Tasara T, Maga G, Hottiger M, et al. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett 2001;507:39-44.
148. Zhu K, Dobard C, Chow S. Requirement for integrase during reverse transcription of HIV type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol 2004;78:5045-55.
149. Hehl E, Joshi P, Kalpana G, et al. Interaction between HIV type 1 reverse transcriptase and integrase proteins. J Virol 2004;78:5056-67.
150. Oz I, Avidan O, Hizi A. Inhibition of the integrases of HIV type 1 and type 2 by reverse transcriptases. Biochem J 2002;361:557-66.
151. Hannon G, Rossi J. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-8.